FDA Approved: BIVALIRUDIN — Original Application (MAIA Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved bivalirudin under an original application from MAIA Pharmaceuticals, labeling it as an anticoagulant for use during certain coronary procedures…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• Bivalirudin (bivalirudin)

Snippet

ORIG AP for BIVALIRUDIN (BIVALIRUDIN)